Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier W Sanders

Showing results (21-30 of 325) with videos related to

Pageof 33
Sort By:
Current Pharmaceutical Design|December 7, 2010
Inhibition of HIV-1 by fusion inhibitorsDirk Eggink, Ben Berkhout, Rogier W Sanders
Current HIV Research|June 13, 2025
Germline-targeting Strategies to Induce bNAbs against HIV-1Tugba Atabey, Rogier W Sanders, Yoann Aldon
BMJ (Clinical Research Ed.)|October 8, 2009
The future of influenza vaccinesMenno D de Jong, Rogier W Sanders
The Lancet. HIV|April 20, 2019
Broadly neutralising antibodies in post-treatment controlGodelieve J de Bree, Rogier W Sanders
Retrovirology|September 14, 2018
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodiesAlba Torrents de la Peña, Rogier W Sanders
Current Opinion in HIV and AIDS|April 20, 2017
Stabilized HIV-1 envelope glycoprotein trimers for vaccine useMax Medina-Ramírez, Rogier W Sanders, Quentin J Sattentau
Expert Review of Vaccines|March 11, 2014
Targeting B-cell germlines and focusing affinity maturation: the next hurdles in HIV-1-vaccine development?Max Medina-Ramírez, Rogier W Sanders, Per Johan Klasse
Scientific American|December 23, 2016
HIV's Achilles' HeelRogier W Sanders, Ian A Wilson, John P Moore
Plos One|September 24, 2014
Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRILGözde Isik, Kwinten Sliepen, Thijs van Montfort, et al.
Trends in Immunology|February 13, 2016
HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing AntibodiesSteven W de Taeye, John P Moore, Rogier W Sanders
Pageof 33

Showing results (21-30 of 325) with videos related to

Sort By:
Pageof 33
Current Pharmaceutical Design|December 7, 2010
Inhibition of HIV-1 by fusion inhibitorsDirk Eggink, Ben Berkhout, Rogier W Sanders
Current HIV Research|June 13, 2025
Germline-targeting Strategies to Induce bNAbs against HIV-1Tugba Atabey, Rogier W Sanders, Yoann Aldon
BMJ (Clinical Research Ed.)|October 8, 2009
The future of influenza vaccinesMenno D de Jong, Rogier W Sanders
The Lancet. HIV|April 20, 2019
Broadly neutralising antibodies in post-treatment controlGodelieve J de Bree, Rogier W Sanders
Retrovirology|September 14, 2018
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodiesAlba Torrents de la Peña, Rogier W Sanders
Current Opinion in HIV and AIDS|April 20, 2017
Stabilized HIV-1 envelope glycoprotein trimers for vaccine useMax Medina-Ramírez, Rogier W Sanders, Quentin J Sattentau
Expert Review of Vaccines|March 11, 2014
Targeting B-cell germlines and focusing affinity maturation: the next hurdles in HIV-1-vaccine development?Max Medina-Ramírez, Rogier W Sanders, Per Johan Klasse
Scientific American|December 23, 2016
HIV's Achilles' HeelRogier W Sanders, Ian A Wilson, John P Moore
Plos One|September 24, 2014
Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRILGözde Isik, Kwinten Sliepen, Thijs van Montfort, et al.
Trends in Immunology|February 13, 2016
HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing AntibodiesSteven W de Taeye, John P Moore, Rogier W Sanders
Pageof 33